West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Independent Advisor Alliance

Independent Advisor Alliance boosted its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 23.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,081 shares of the medical instruments supplier’s stock after acquiring an additional 389 shares during the period. Independent Advisor Alliance’s holdings in West Pharmaceutical Services were worth $625,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WST. Kennedy Capital Management LLC acquired a new position in West Pharmaceutical Services during the 1st quarter worth approximately $1,511,000. B. Riley Wealth Advisors Inc. acquired a new position in West Pharmaceutical Services during the 1st quarter worth approximately $211,000. Tidal Investments LLC grew its holdings in West Pharmaceutical Services by 54.7% during the 1st quarter. Tidal Investments LLC now owns 10,574 shares of the medical instruments supplier’s stock worth $4,181,000 after acquiring an additional 3,738 shares in the last quarter. Plato Investment Management Ltd acquired a new position in West Pharmaceutical Services during the 1st quarter worth approximately $351,000. Finally, Wahed Invest LLC lifted its position in shares of West Pharmaceutical Services by 15.2% during the 1st quarter. Wahed Invest LLC now owns 1,454 shares of the medical instruments supplier’s stock worth $575,000 after buying an additional 192 shares during the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Insiders Place Their Bets

In other news, VP Charles Witherspoon sold 703 shares of the company’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total transaction of $218,211.20. Following the transaction, the vice president now directly owns 1,253 shares of the company’s stock, valued at $388,931.20. This represents a 35.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.53% of the stock is owned by insiders.

West Pharmaceutical Services Stock Up 1.2 %

Shares of NYSE:WST opened at $323.32 on Thursday. The company has a market capitalization of $23.41 billion, a PE ratio of 47.97, a P/E/G ratio of 24.15 and a beta of 1.00. The company has a current ratio of 3.00, a quick ratio of 2.23 and a debt-to-equity ratio of 0.07. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The firm has a 50 day simple moving average of $307.93 and a 200-day simple moving average of $313.27.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.35. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The business had revenue of $746.90 million during the quarter, compared to the consensus estimate of $709.62 million. During the same quarter in the previous year, the firm earned $2.16 EPS. The company’s revenue was down .1% compared to the same quarter last year. On average, equities analysts predict that West Pharmaceutical Services, Inc. will post 6.67 EPS for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 20th. Shareholders of record on Wednesday, November 13th were given a dividend of $0.21 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a yield of 0.26%. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. West Pharmaceutical Services’s dividend payout ratio is presently 12.46%.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.